Decay-accelerating factor (CD55) and membrane inhibitor of reactive lysis (CD59) are released within exosomes during in vitro maturation of reticulocytes

被引:120
|
作者
Rabesandratana, H
Toutant, JP
Reggio, H
Vidal, M
机构
[1] Univ Montpellier 2, UMR 5539, F-34095 Montpellier, France
[2] Hop St Eloi, Cent Hematol Lab, Montpellier, France
[3] INRA, F-34060 Montpellier, France
关键词
D O I
10.1182/blood.V91.7.2573.2573_2573_2580
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Exosomes are membrane vesicles released by reticulocytes during their maturation into erythrocytes. They have a clearing function because of their enrichment with some proteins known to decrease or disappear from the cell surface during maturation, eg, acetylcholinesterase (AChE) and transferrin receptor (TIR), respectively. To better understand the molecular events leading to protein sorting in exosomes, we analyzed the expression of glycosylphosphatidylinositol (GPI)-anchored proteins on the exosome surface through a technique involving bead coupling and flow cytometry immunodetection. The presence of AChE, decay-accelerating factor (DAF), membrane inhibitor of reactive lysis (MIRL), and lymphocyte function-associated antigen 3 (LFA-3) on the surface of exosomes obtained from normal and paroxysmal nocturnal hemoglobinuria (PNH) reticulocytes, suggests that (1) the GPI anchor is efficiently sorted during exosome formation, (2) exosome release could account for the observed discrepancy in GPI-protein expression between reticulocytes and erythrocytes from PNH patients, and (3) exosomes could have another physiologic function related to controlling membrane attack complex formation. (C) 1998 by The American Society of Hematology.
引用
收藏
页码:2573 / 2580
页数:8
相关论文
共 50 条
  • [21] EXPRESSION OF DECAY-ACCELERATING FACTOR (CD55) OF THE COMPLEMENT-SYSTEM ON HUMAN SPERMATOZOA
    CERVONI, F
    OGLESBY, TJ
    FENICHEL, P
    DOHR, G
    ROSSI, B
    ATKINSON, JP
    HSI, BL
    JOURNAL OF IMMUNOLOGY, 1993, 151 (02): : 939 - 948
  • [22] Decay-accelerating factor but not CD59 limits experimental immune-complex glomerulonephritis
    Bao, Lihua
    Haas, Mark
    Minto, Andrew W.
    Quigg, Richard J.
    LABORATORY INVESTIGATION, 2007, 87 (04) : 357 - 364
  • [23] Prostaglandin E2 regulates the complement inhibitor CD55/decay-accelerating factor in colorectal cancer
    Holla, VR
    Wang, DZ
    Brown, JR
    Mann, JR
    Katkuri, S
    Dubois, RN
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (01) : 476 - 483
  • [24] COMPLEMENT REGULATORY PROTEINS AT THE FETOMATERNAL INTERFACE DURING HUMAN PLACENTAL DEVELOPMENT - DISTRIBUTION OF CD59 BY COMPARISON WITH MEMBRANE COFACTOR PROTEIN (CD46) AND DECAY ACCELERATING FACTOR (CD55)
    HOLMES, CH
    SIMPSON, KL
    OKADA, H
    OKADA, N
    WAINWRIGHT, SD
    PURCELL, DFJ
    HOULIHAN, JM
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1992, 22 (06) : 1579 - 1585
  • [25] MARKEDLY HIGH POPULATION OF AFFECTED RETICULOCYTES NEGATIVE FOR DECAY-ACCELERATING FACTOR (DAF) AND CD59 IN PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA
    IWAMOTO, N
    KAWAGUCHI, T
    NAGAKURA, S
    TAKATSUKI, K
    NAKAKUMA, H
    BLOOD, 1994, 84 (10) : A11 - A11
  • [26] EXPRESSION AND REGULATION OF DECAY-ACCELERATING FACTOR (CD55), MEMBRANE COFACTOR PROTEIN (CD46) AND CD59 IN THE HUMAN ASTROGLIOMA CELL-LINE, D54-MG, AND PRIMARY RAT ASTROCYTES
    YANG, C
    BARNUM, SR
    JOURNAL OF IMMUNOLOGY, 1993, 150 (08): : A227 - A227
  • [27] Antigen-presenting cell exosomes are protected from complement-mediated lysis by expression of CD55 and CD59
    Clayton, A
    Harris, CL
    Court, J
    Mason, MD
    Morgan, BP
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2003, 33 (02) : 522 - 531
  • [28] Decay-accelerating factor (DAF/CD55) is a functional active element of the LPS receptor complex
    Heine, H
    Ulmer, AJ
    El-Samalouti, VT
    Lentschat, A
    Hamann, L
    JOURNAL OF ENDOTOXIN RESEARCH, 2001, 7 (03): : 227 - 231
  • [29] DEFICIENCY OF COMPLEMENT DECAY-ACCELERATING FACTOR (DAF, CD55) IN NON-HODGKINS-LYMPHOMA
    FUKUDA, H
    SEYA, T
    HARA, T
    MATSUMOTO, M
    KINOSHITA, T
    MASAOKA, T
    IMMUNOLOGY LETTERS, 1991, 29 (03) : 205 - 210
  • [30] Mechanisms by which the surface expression of the glyeosyl-phosphatidylinositol-anchored complement regulatory proteins decay-accelerating factor (CD55) and CD59 is lost in human leukaemia cell lines
    Hatanaka, M
    Seya, T
    Matsumoto, M
    Hara, T
    Nonaka, M
    Inoue, N
    Takeda, J
    Shimizu, A
    BIOCHEMICAL JOURNAL, 1996, 314 : 969 - 976